DrugPatentWatch Database Preview
Drugs in Development Information for D-glucose
Email this page to a colleague
See Plans and PricingWhat is the drug development status for D-glucose?
D-glucose is an investigational drug.
There have been 31 clinical trials for D-glucose.
The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2009.
The most common disease conditions in clinical trials are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, and Carcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), M.D. Anderson Cancer Center, and University of Maryland.
Summary for D-glucose
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 72 |
| WIPO Patent Applications | 25 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2009-09-01) |
| Vendors | 24 |
Recent Clinical Trials for D-glucose
| Title | Sponsor | Phase |
|---|---|---|
| 18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules | Canary Foundation | Phase 2 |
| 18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules | Stanford University | Phase 2 |
| Fluorine F 18 Fluorthanatrace PET/CT in Treating Participants With Primary or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | National Cancer Institute (NCI) | Phase 1 |
Clinical Trial Summary for D-glucose
Top disease conditions for D-glucose
Top clinical trial sponsors for D-glucose
US Patents for D-glucose
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
